International Journal of Medical and Pharmaceutical Research
2023, Volume-4, Issue-3 doi: 10.5281/zenodo.8007099
Original Article
Impact of COVID-19 Vaccination Status on Mortality of COVID-19 Patients In Tertiary Care Centre, Karnataka
 ,
 ,
 ,
 ,
Published
June 5, 2023
Abstract
Background: The COVID-19 pandemic has resulted in significant morbidity and mortality worldwide, prompting the development and distribution of effective vaccines. The impact of vaccination status on COVID-19 patient outcomes remains a critical area of investigation to inform public health strategies and promote vaccine uptake. This study was conducted to investigate the association between COVID-19 vaccination status and mortality in patients admitted to a tertiary care centre in Karnataka. Methods: A retrospective cohort study was conducted involving 300 patients, divided into three groups: 100 completely vaccinated, 100 partially vaccinated, and 100 unvaccinated. All patients were symptomatic for COVID-19 and admitted to HIMS hospital, where SARS-CoV-2 was detected using Real-time reverse transcriptase polymerase chain reaction (RT-PCR) and Rapid Antigen Test (RAT). Mortality outcomes were compared across the three groups, adjusting for age, sex, and comorbidities. Results: The mortality rate was significantly lower in the completely vaccinated group (8%) compared to the partially vaccinated (20%) and unvaccinated groups (32%) (p < 0.05). The adjusted odds ratio (OR) of mortality, after controlling for confounding factors, was 2.42 (95% CI: 1.01-5.81) for the partially vaccinated group and 3.12 (95% CI: 1.25-7.79) for the unvaccinated group compared to the completely vaccinated group. Conclusion: Our findings demonstrate a significant protective effect of complete COVID-19 vaccination against severe outcomes, including mortality, among patients admitted to a tertiary care center in Karnataka. These results emphasize the importance of widespread vaccination campaigns to mitigate the impact of the COVID-19 pandemic and encourage public health efforts to promote vaccine uptake.
Recommended Articles
Loading Image...
Volume-4, Issue-3
Citations
1563 Views
422 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved